カワムラ ヒデマサ
KAWAMURA Hidemasa
河村 英将 所属 埼玉医科大学 医学部 総合医療センター 放射線科(画像診断・核医学科、放射線腫瘍科) 職種 教授 |
|
論文種別 | 学術雑誌(原著) |
言語種別 | 日本語 |
査読の有無 | 査読なし |
表題 | Prospective observational study of patients treated with carbon-ion radiotherapy for non-squamous cell carcinoma of the head and neck in Gunma university |
掲載誌名 | 正式名:Japanese Journal of Head and Neck Cancer ISSNコード:1881-8382 |
出版社 | Japan Society for Head and Neck Cancer |
巻・号・頁 | 47(1),53-58頁 |
著者・共著者 | Atsushi Musha,Nobuteru Kubo,Naoko Okano,Takuya Kaminuma,Hidemasa Kawamura,Hiro Sato,Yukihiro Takayasu,Masato Shino,Osamu Nikkuni,Shota Ida,Katsuyuki Shirai,Jun-Ichi Saitoh,Masaru Ogawa,Satoshi Yokoo,Kazuaki Chikamatsu,Tatsuya Ohno |
発行年月 | 2021 |
概要 | Gunma University has been utilizing carbon-ion radiotherapy as a treatment for head and neck cancer since 2010. We evaluated the long-term efficacy and safety of carbon-ion radiotherapy for non-squamous cell carcinoma of the head and neck in 35 patients enrolled in a pective study at the Gunma University Heavy Ion Medical Center (from 2010 to 2014). The median age of the patients was 59 years (range, 31-77 years). The median follow-up time for all the patients was 65 months (range, 6.1-98.8 months). Thirty-two and three patients received 64.0 Gy (relative biological effectiveness) and 57.6 Gy (relative biological effectiveness) in 16 fractions, respectively. The T-classification was 5/8/22 in T2/3/4, respectively, and the tumors were inoperable in 20 cases (57%). The maxillary sinus and nasal cavity were the most common sites for tumors in 9 cases (26%). Adenoid cystic carcinoma was dominant, with this carcinoma being found in 21 cases (60%). The 5-year local control, progression-free survival, and overall survival rates were 74.5%, 53.2%, and 81.3%, respectively. Nine patients had local recurrence, and six patients died. Acute and late adverse events were evaluated according to the Common Terminology Criteria for Adverse Events, version 4.0. Over acute grade 3 radiation mucositis (8 cases) improved immediately with conservative therapy. Late grade 4 adverse events were observed these were two cases of visual loss and one case of brain necrosis. There were no grade 5 adverse events. Carbon-ion radiotherapy achieved excellent local control and overall survival rates for non-squamous cell carcinoma. |
DOI | 10.5981/jjhnc.47.53 |